SALE
市場調查報告書

呼吸疾病檢驗的全球市場:各產品、服務,檢驗類型,疾病,目的,終端用戶,地區預測及機會(2025年)

Global Respiratory Disease Testing Market By Product and Service, By Test Type, By Disease, By Purpose, By End User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 938729
出版日期 內容資訊 英文 115 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

呼吸疾病檢驗的全球市場:各產品、服務,檢驗類型,疾病,目的,終端用戶,地區預測及機會(2025年) Global Respiratory Disease Testing Market By Product and Service, By Test Type, By Disease, By Purpose, By End User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 115 Pages
簡介

全球呼吸疾病檢驗市場,由罹患呼吸疾病的患者增加所帶動。再加上全球的政府醫療保健基礎設施投資著,給予在預測期間內的市場成長積極的影響。還有,研究開發活動的增加,預計更加促進今後數年的市場成長。

本報告提供全球呼吸疾病檢驗市場相關相關分析,市場規模、佔有率、預測,各市場區隔分析,競爭分析,市場趨勢的變化等相關的系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球呼吸疾病檢驗市場的影響

第4章 摘要整理

第5章 顧客的迴響

第6章 全球呼吸疾病檢驗市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品及服務(設備和設備,化驗和試劑,服務和軟體)
    • 各檢驗類型(機械性檢驗,OSA診斷檢驗,其他檢驗類型,影像檢查,傳統的診斷檢驗,分子診斷檢驗)
    • 各疾病(結核,氣喘,肺癌症,慢性阻塞性肺病,其他呼吸疾病)
    • 各目的(每分鐘通風量,頂峰吸氣流量(PIF),吸氣呼氣容量(IVC),頂峰呼氣流量(PEF),強制呼氣容量(FVC),強制呼氣數量(FEV1),其他)
    • 各終端用戶(醫院/臨床檢驗室,參照檢驗室,診療所,其他終端用戶)
    • 各企業(2019)
    • 各地區
  • 市場魅力指數

第7章 亞太地區呼吸疾病檢驗市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品及服務
    • 各檢驗類型
    • 各疾病
    • 各目的
    • 各終端用戶
    • 各國
    • 競爭的展望
  • 亞太地區:國家分析
    • 中國呼吸疾病檢驗市場展望
    • 印度呼吸疾病檢驗市場展望
    • 澳洲呼吸疾病檢驗市場展望
    • 日本呼吸疾病檢驗市場展望
    • 韓國呼吸疾病檢驗市場展望

第8章 歐洲呼吸疾病檢驗市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品及服務
    • 各檢驗類型
    • 各疾病
    • 各目的
    • 各終端用戶
    • 各國
    • 競爭的展望
  • 歐洲:國家分析
    • 法國呼吸疾病檢驗市場展望
    • 德國呼吸疾病檢驗市場展望
    • 英國呼吸疾病檢驗市場展望
    • 義大利呼吸疾病檢驗市場展望
    • 西班牙呼吸疾病檢驗市場展望

第9章 北美呼吸疾病檢驗市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品及服務
    • 各檢驗類型
    • 各疾病
    • 各目的
    • 各終端用戶
    • 各國
    • 競爭的展望
  • 北美:國家分析
    • 美國的呼吸疾病檢驗市場展望
    • 墨西哥呼吸疾病檢驗市場展望
    • 加拿大呼吸疾病檢驗市場展望

第10章 南美呼吸疾病檢驗市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品及服務
    • 各檢驗類型
    • 各疾病
    • 各目的
    • 各終端用戶
    • 各國
    • 競爭的展望
  • 南美:國家分析
    • 巴西呼吸疾病檢驗市場展望
    • 阿根廷呼吸疾病檢驗市場展望
    • 哥倫比亞呼吸疾病檢驗市場展望

第11章 中東、非洲呼吸疾病檢驗市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各產品及服務
    • 各檢驗類型
    • 各疾病
    • 各目的
    • 各終端用戶
    • 各國
    • 競爭的展望
  • 中東、非洲:國家分析
    • 南非呼吸疾病檢驗市場展望
    • 沙烏地阿拉伯呼吸疾病檢驗市場展望
    • UAE呼吸疾病檢驗市場展望

第12章 市場動態

  • 成長要素
  • 課題

第13章 市場趨勢

第14章 專利分析

第15章 競爭情形

  • Philips Healthcare
  • Becton, Dickinson & Company
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Biomerieux
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Cosmed
  • Seegene Inc.
  • Sdi Diagnostics
  • Bosch Healthcare Solutions
  • ADI Instruments
  • Qiagen
  • Siemens Healthcare
  • Co-Diagnostics, Inc.

第16章 策略性建議

第17章 免責聲明

目錄
Product Code: 4698

Global respiratory disease testing market is expected to grow at a CAGR during the forecast period. The global respiratory disease testing market is driven by the rising population having respiratory disorders. Moreover, governments across the globe are investing more on healthcare infrastructure, which is anticipated to positively impact the growth of market during the forecast period. Also, increase in research and developmental activities is further expected to bolster the growth of market over the next few years.

The global respiratory disease testing market is segmented based on product and service, test type, disease, purpose, end user, company, and region. Based on product and service, the market can be categorized into instruments & devices, assays & reagents, services & software. Out of which, the instruments & devices segment dominated the market in terms of largest market share during the forecast period and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to the constant need of diagnostic instruments and devices in laboratories, point-of-care, and home care. Also, the services and software segment are forecast to register high growth over the coming years on account of rapid technological innovations. In terms of test type, the market is fragmented into mechanical tests, OSA diagnostic tests, other test types, imaging tests, traditional diagnostic tests and molecular diagnostic tests. Among them, traditional diagnostic tests segment is anticipated to dominate the market during the next five years which can be primarily attributed to the quick turnaround time of these tests.

Major players operating in the global respiratory disease testing market include Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Biomerieux, Alere Inc., Bio-Rad Laboratories, Inc., Cosmed, Seegene Inc, Sdi Diagnostics, Bosch Healthcare Solutions, ADI Instruments, Qiagen, Siemens Healthcare, Co-Diagnostics, Inc., and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global respiratory disease testing market from 2015 to 2018.
  • To estimate and forecast the market size of global respiratory disease testing market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global respiratory disease testing market based on product and service, test type, disease, purpose, end user, company and regional distribution.
  • To identify dominant region or segment in the global respiratory disease testing market.
  • To identify drivers and challenges for global respiratory disease testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global respiratory disease testing market.
  • To conduct pricing analysis for global respiratory disease testing market.
  • To identify and analyze the profile of leading players operating in global respiratory disease testing market.
  • To identify key sustainable strategies adopted by market players in global respiratory disease testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global respiratory disease testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Respiratory disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to respiratory disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global respiratory disease testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Respiratory Disease Testing Market, By Product and Service:

Instruments & Devices

Assays & Reagents

Services & Software

  • Global Respiratory Disease Testing Market, By Test Type:

Mechanical Tests

OSA Diagnostic Tests

Other Test Types

Imaging Tests

Traditional Diagnostic Tests

Molecular Diagnostic Tests

  • Global Respiratory Disease Testing Market, By Disease:

Tuberculosis

Asthma

Lung Cancer

Chronic Obstructive Pulmonary Disease

Other Respiratory Diseases

  • Global Respiratory Disease Testing Market, By Purpose:

Minute Ventilation

Peak Inspiratory flow (PIF)

Inspiratory Vital Capacity (IVC)

Peak Expiratory Flow (PEF)

Forced Vital Capacity (FVC)

Forced Expiratory Volume (FEV1)

Others

  • Global Respiratory Disease Testing Market, By End User:

Hospital/Clinical Laboratories

Reference Laboratories

Physician Offices

Others

  • Global Respiratory Disease Testing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global respiratory disease testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Respiratory Disease Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Respiratory Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Service (Instruments & Devices, Assays & Reagents, Services & Software)
    • 6.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Tests, Other Test Types, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests)
    • 6.2.3. By Disease (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Other Respiratory Diseases)
    • 6.2.4. By Purpose (Minute Ventilation, Peak Inspiratory flow (PIF), Inspiratory Vital Capacity (IVC), Peak Expiratory Flow (PEF), Forced Vital Capacity (FVC), Forced Expiratory Volume (FEV1), Others)
    • 6.2.5. By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Other End Users)
    • 6.2.6. By Company (2019)
    • 6.2.7. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Respiratory Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Test Type
    • 7.2.3. By Disease
    • 7.2.4. By Purpose
    • 7.2.5. By End User
    • 7.2.6. By Country
    • 7.2.7. Competition Outlook
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Respiratory Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Disease
        • 7.3.1.2.4. By End User
    • 7.3.2. India Respiratory Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Disease
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Respiratory Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Disease
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Respiratory Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Disease
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Respiratory Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Disease
        • 7.3.5.2.4. By End User

8. Europe Respiratory Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Test Type
    • 8.2.3. By Disease
    • 8.2.4. By Purpose
    • 8.2.5. By End User
    • 8.2.6. By Country
    • 8.2.7. Competition Outlook
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Respiratory Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Disease
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Respiratory Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Disease
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Respiratory Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Disease
        • 8.3.3.2.4. By End Use
    • 8.3.4. Italy Respiratory Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By Disease
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Respiratory Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By Disease
        • 8.3.5.2.4. By End User

9. North America Respiratory Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Test Type
    • 9.2.3. By Disease
    • 9.2.4. By Purpose
    • 9.2.5. By End User
    • 9.2.6. By Country
    • 9.2.7. Competition Outlook
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Respiratory Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Disease
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Respiratory Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Disease
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Respiratory Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Disease
        • 9.3.3.2.4. By End User

10. South America Respiratory Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Test Type
    • 10.2.3. By Disease
    • 10.2.4. By Purpose
    • 10.2.5. By End User
    • 10.2.6. By Country
    • 10.2.7. Competition Outlook
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Respiratory Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Disease
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Respiratory Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Disease
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Respiratory Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Disease
        • 10.3.3.2.4. By End Use

11. Middle East and Africa Respiratory Disease Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product and Service
    • 11.2.2. By Test Type
    • 11.2.3. By Disease
    • 11.2.4. By Purpose
    • 11.2.5. By End User
    • 11.2.6. By Country
    • 11.2.7. Competition Outlook
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Respiratory Disease Testing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product and Service
        • 11.3.1.2.2. By Test Type
        • 11.3.1.2.3. By Disease
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Respiratory Disease Testing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product and Service
        • 11.3.2.2.2. By Test Type
        • 11.3.2.2.3. By Disease
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Respiratory Disease Testing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product and Service
        • 11.3.3.2.2. By Test Type
        • 11.3.3.2.3. By Disease
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Philips Healthcare
  • 15.2. Becton, Dickinson & Company
  • 15.3. Abbott Laboratories
  • 15.4. Thermo Fisher Scientific Inc.
  • 15.5. Biomerieux
  • 15.6. Alere Inc.
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. Cosmed
  • 15.9. Seegene Inc.
  • 15.10. Sdi Diagnostics
  • 15.11. Bosch Healthcare Solutions
  • 15.12. ADI Instruments
  • 15.13. Qiagen
  • 15.14. Siemens Healthcare
  • 15.15. Co-Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer